rs767795583
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_005050.4(ABCD4):c.1588C>T(p.Gln530*) variant causes a stop gained change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000185 in 1,460,986 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_005050.4 stop_gained
Scores
Clinical Significance
Conservation
Publications
- methylmalonic acidemia with homocystinuria, type cblJInheritance: AR Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), G2P, Orphanet, Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| ABCD4 | NM_005050.4 | c.1588C>T | p.Gln530* | stop_gained | Exon 17 of 19 | ENST00000356924.9 | NP_005041.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000401 AC: 1AN: 249354 AF XY: 0.00 show subpopulations
GnomAD4 exome AF: 0.0000185 AC: 27AN: 1460986Hom.: 0 Cov.: 31 AF XY: 0.0000179 AC XY: 13AN XY: 726754 show subpopulations
Age Distribution
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Methylmalonic acidemia with homocystinuria, type cblJ Pathogenic:2
The stop gained c.1588C>T (p.Gln530Ter) variant has been submitted to ClinVar as Pathogenic but no evidences are provided for independent assessment. This p.Gln530Ter variant has allele frequency of 0.00040% in the gnomAD and novel (not in any individuals) in 1000 genome database. The nucleotide change c.1588C>T in ABCD4 is predicted as conserved by GERP++ and PhyloP across 100 vertebrates. This variant is predicted to cause loss of normal protein function through protein truncation. Loss of function variants have been previously reported to be disease causing. For these reasons, this variant has been classified as Likely Pathogenic. In the absence of another variant in ABCD4 gene, the molecular diagnosis can not be confirmed. The above variant has also been detected in the proband's father. -
For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in ABCD4 are known to be pathogenic (PMID: 22922874). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site, but this prediction has not been confirmed by published transcriptional studies. This variant has not been reported in the literature in individuals with ABCD4-related disease. This variant is present in population databases (rs767795583, ExAC 0.002%). This sequence change creates a premature translational stop signal (p.Gln530*) in the ABCD4 gene. It is expected to result in an absent or disrupted protein product. -
Cobalamin C disease Pathogenic:1
Variant summary: ABCD4 c.1588C>T (p.Gln530X) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been observed in association with inborn error of vitamin B12 metabolism in the HGMD database. The variant allele was found at a frequency of 4e-06 in 249354 control chromosomes. To our knowledge, no occurrence of c.1588C>T in individuals affected with Methylmalonic Acidemia With Homocystinuria and no experimental evidence demonstrating its impact on protein function have been reported. One clinical diagnostic laboratory has submitted clinical-significance assessments for this variant to ClinVar after 2014 and classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
not provided Pathogenic:1
Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss of function is a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); Has not been previously published as pathogenic or benign to our knowledge -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at